Latest updates
- Company news Exonate shortlisted for UKBAA Best Investment in a High Growth Female Founder Award
- In the press Listen to Exonate’s CEO Dr Catherine Beech speak at The Commonwealth Innovation Forum (TCIF) in Brisbane held on Thursday 5th April 2018.
- In the press Exonate’s CEO, Dr Catherine Beech, to present at BioTrinity 2018
- In the press Watch Exonate’s Chairman Sunil Shah and Angel Co Fund Investor Peter Cowley, feature in the British Business Bank Finance Guide video
- In the press Exonate announces the formation of ophthalmology Clinical Advisory Board (“Exonate” or the “Company”)
- In the press Exonate is the ‘One to Watch’ in the Best Investment in Life Sciences
- In the press Exonate receives Wellcome Trust funding to develop eye drop treatment for wet age-related macular degeneration (wet AMD)
- Company news Exonate closes successful funding round – to develop eye drops treatment for wet age-related macular degeneration (wet AMD)
- Company news Dr Jenny Batson awarded the David Meyer Research Prize
- Company news Exonate closes second successful funding round
- Company news Nottingham Angels and Fusion IP make first investment in University spin-out business, Exonate